Cargando…
Serum Cystatin C and Coronavirus Disease 2019: A Potential Inflammatory Biomarker in Predicting Critical Illness and Mortality for Adult Patients
This study aimed at determining the relationship between baseline cystatin C levels and coronavirus disease 2019 (COVID-19) and investigating the potential prognostic value of serum cystatin C in adult patients with COVID-19. 481 patients with COVID-19 were consecutively included in this study from...
Autores principales: | Chen, Dan, Sun, Wenwu, Li, Jia, Wei, Bohua, Liu, Wei, Wang, Xiaopin, Song, Fan, Chen, Liangkai, Yang, Junhui, Yu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545455/ https://www.ncbi.nlm.nih.gov/pubmed/33061826 http://dx.doi.org/10.1155/2020/3764515 |
Ejemplares similares
-
Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19
por: Li, Yan, et al.
Publicado: (2020) -
Serum cystatin C is a poor biomarker for diagnosing acute kidney injury in critically-ill children
por: Hamed, Hanan M., et al.
Publicado: (2013) -
Divergence between serum creatine and cystatin C in estimating glomerular filtration rate of critically ill COVID-19 patients
por: Liu, Yanan, et al.
Publicado: (2021) -
Urine interleukin-18 and cystatin-C as biomarkers of acute kidney injury in critically ill neonates
por: Li, Yanhong, et al.
Publicado: (2012) -
Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates
por: Leroux, Stéphanie, et al.
Publicado: (2021)